1 Min Read
Oct 7 (Reuters) - Easywell Biomedical Inc :
* Says its unit applied clinical trial to TFDA for TWB-103 that a fetal skin cells wound dressing
Source text in Chinese: goo.gl/mFGCmA
Further company Coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.